Why Medifast (MED) Stock Is Up TodayShares of wellness company Medifast (
NYSE:MED)
jumped 4.1% in the morning session after the company reported second-quarter financial results that surpassed analyst expectations. The company's revenue of $105.6 million and earnings per share of $0.22 both came in ahead of Wall Street's forecasts. This performance marked a significant turnaround in profitability, as the company posted a net income of $2.5 million compared to a net loss of $8.2 million in the same quarter of the previous year. These results arrived despite a 37.4% year-over-year drop in revenue, driven by a 32.7% decrease in active coaches. Investors appeared to overlook weak guidance for the upcoming quarter, focusing instead on the earnings beat and a strong balance sheet that reported $162.7 million in cash with no debt.
Medifast (NYSE:MED) Exceeds Q2 Expectations But Quarterly Revenue Guidance Misses ExpectationsWellness company Medifast (
NYSE:MED) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, but sales fell by 37.4% year on year to $105.6 million. On the other hand, next quarter’s revenue guidance of $80 million was less impressive, coming in 14.7% below analysts’ estimates. Its GAAP profit of $0.22 per share was significantly above analysts’ consensus estimates.
Medifast Announces Second Quarter 2025 Financial Results
Medifast (
NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarter ended June 30, 2025.
Medifast (MED) Reports Q2: Everything You Need To Know Ahead Of EarningsWellness company Medifast (
NYSE:MED)
will be reporting earnings this Monday afternoon. Here’s what you need to know.
3 Unpopular Stocks We Keep Off Our RadarWall Street has issued downbeat forecasts for the stocks in this article.
These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.
Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2025
Medifast (
NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the quarter ended June 30, 2025 on Monday, August 4, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
1 Consumer Stock on Our Watchlist and 2 We QuestionConsumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. But they’re also double-edged swords as they often lag in booming conditions, and this pattern has persisted recently.
Over the past six months, the industry has recorded a loss of 7.4%, a far cry from the S&P 500’s 4.1% ascent.
1 Unprofitable Stock on Our Buy List and 2 to Approach with CautionRunning at a loss can be a red flag.
Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
2 Cash-Heavy Stocks to Keep an Eye On and 1 to IgnoreCompanies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments.
Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.
Monday.com, Oxford Industries, and Medifast Stocks Trade Up, What You Need To KnowA number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%) as reports pointed to easing tensions between Israel and Iran. The Wall Street Journal said senior Iranian officials had signaled a willingness to restart stalled nuclear talks, on the condition that Washington refrain from joining Israel's ongoing strikes.
This development triggered a significant decline in oil prices, easing inflation concerns.
Also, it is possible some investors were buying the dip following the sell-off at the end of the previous week.
1 Safe-and-Steady Stock on Our Watchlist and 2 to QuestionLow-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
Personal Care Stocks Q1 In Review: Medifast (NYSE:MED) Vs PeersLet’s dig into the relative performance of Medifast (
NYSE:MED) and its peers as we unravel the now-completed Q1 personal care earnings season.
1 Stock Under $50 Worth Your Attention and 2 to AvoidThe $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead.
They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
MED Q1 Earnings Call: Revenue Misses, Coach Productivity and GLP-1 Strategy in FocusWellness company Medifast (
NYSE:MED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 33.8% year on year to $115.7 million. Next quarter’s revenue guidance of $95 million underwhelmed, coming in 15.4% below analysts’ estimates. Its GAAP loss of $0.07 per share was 72% above analysts’ consensus estimates.
1 Cash-Producing Stock with Impressive Fundamentals and 2 to Think Twice AboutGenerating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Herbalife (HLF) Q1 Earnings: What To ExpectHealth and wellness products company Herbalife (
NYSE:HLF)
will be announcing earnings results tomorrow afternoon. Here’s what to expect.
Medifast (NYSE:MED) Misses Q1 Sales TargetsWellness company Medifast (
NYSE:MED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 33.8% year on year to $115.7 million. Next quarter’s revenue guidance of $95 million underwhelmed, coming in 15.4% below analysts’ estimates. Its GAAP loss of $0.07 per share was 72% above analysts’ consensus estimates.
Medifast Announces First Quarter 2025 Financial Results
Medifast (
NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2025.
Earnings To Watch: Medifast (MED) Reports Q1 Results TomorrowWellness company Medifast (
NYSE:MED)
will be reporting results tomorrow after market hours. Here’s what to expect.
3 Hated Stocks in Hot WaterHitting a new 52-week low can be a pivotal moment for any stock.
These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds.
